$1.60 $0.03 (1.9%)

04:00 PM EST on 11/21/19

Opko Health, Inc. (NASDAQ:OPK)

CAPS Rating: 2 out of 5

Current Price $1.60 Mkt Cap $1.0B
Open $1.58 P/E Ratio 0.00
Prev. Close $1.57 Div. (Yield) $0.00 (0.0%)
Daily Range $1.54 - $1.61 Volume 3,183,366
52-Wk Range $1.33 - $3.94 Avg. Daily Vol. 5,826,229

Caps

How do you think NASDAQ:OPK will perform against the market?

Add Stock to CAPS Watchlist

All Players

238 Outperform
29 Underperform
 

All-Star Players

12 Outperform
13 Underperform
 

Wall Street

3 Outperform
0 Underperform
 

Top NASDAQ:OPK Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

TMFSaintCroix (98.94)
Submitted February 16, 2018

I'm fascinated by Phillip Frost, the biotech billionaire who loves to invest in micro-cap stocks. He and his team have a history of using reverse-mergers to introduce start-ups into the public markets. Presumably they want to avoid all the regulatory… More

allstar31 (99.90)
Submitted September 13, 2014

Uses known stock promoter Redchip.com. Is a pump and dump scam.

Recent Community Commentary

Read the most recent pitches from players about OPK.

Recs

0
Member Avatar TMFBiologyFool (68.64) Submitted: 7/12/2018 5:30:48 PM : Underperform Start Price: $6.23 NASDAQ:OPK Score: +85.48

Up substantially on no apparent news.

Recs

1
Member Avatar TMFSaintCroix (98.94) Submitted: 2/16/2018 6:08:24 PM : Outperform Start Price: $3.88 NASDAQ:OPK Score: -76.33

I'm fascinated by Phillip Frost, the biotech billionaire who loves to invest in micro-cap stocks. He and his team have a history of using reverse-mergers to introduce start-ups into the public markets. Presumably they want to avoid all the regulatory crap that goes along with an IPO. Not to mention banks taking a good chunk of your equity. I feel like Frost is one of the good guys.

I think it's a good idea to follow Frost's investments in CAPS. He did not make his billions in biotech--he made his billions in generic drugs--but he's a medical doctor and a financial whiz. It might be unconventional to bring start-ups into the public markets the way he does. But if you pay attention to his investments, you have an opportunity to invest like a VC, at VC prices.

And I love that he keeps buying shares of his own stock! I expect some short-term volatility, but this is an interesting healthcare company. Outperform.

Recs

0
Member Avatar HereToLearnToo (< 20) Submitted: 5/31/2016 11:56:22 AM : Outperform Start Price: $10.53 NASDAQ:OPK Score: -132.71

From information I've read it appears the table is set for growth.

Also, the CEO Billionaire Phillip Frost has continued to add to his position regularly, so is putting his money where his mouth is...

Leaderboard

Find the members with the highest scoring picks in OPK.

Score Leader

avatre

avatre (< 20) Score: +238.50

The Score Leader is the player with the highest score across all their picks in OPK.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
avatre < 20 6/15/2009 Underperform 5Y $1.68 -4.76% +233.74% +238.50 0 Comment
gmxBatteringRam 29.42 8/5/2009 Underperform 5Y $2.05 -21.95% +212.01% +233.96 0 Comment
goldminingXpert 28.61 6/15/2010 Underperform 5Y $2.06 -22.33% +180.34% +202.67 1 Comment
EcoUSA 99.46 11/12/2010 Underperform 5Y $2.95 -45.76% +156.86% +202.62 0 Comment
haimp 26.78 10/7/2010 Underperform 5Y $2.31 -30.74% +167.88% +198.62 0 Comment
XMFConnor 96.48 5/16/2012 Underperform 5Y $4.62 -65.37% +131.70% +197.07 0 Comment
Covestor 80.47 3/14/2011 Underperform NS $3.76 -57.45% +139.18% +196.63 1 Comment
shorttest4 32.76 3/8/2010 Underperform 5Y $2.06 -22.33% +171.61% +193.94 0 Comment
stratisticalarb 97.64 4/26/2011 Underperform 1Y $3.99 -59.90% +130.29% +190.20 0 Comment
This player feels very strongly about this pick and has marked it a Top Pick. Top Picks do not affect a player’s score. superdealsonly 48.36 2/4/2013 Underperform 5Y $6.81 -76.51% +106.45% +182.96 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for OPK.